2 Monotherapy is no longer available in the USA since Jan 2023, and lixisenatide-glargine (iGlarLixi) has been approved for type 2 diabetes
Starich GH, Bar RS, Mazzaferri EL
In short, Ang-2 promotes angiogenesis, whereas Ang-1 inhibits it (194)
demonstrated that quercetin-3-O-rutinoside a specific flavonoid found in moringa inhibits -glucosidase while simultaneously increasing GLP-1 secretion, an effect documented in both healthy individuals and type 2 diabetic patients
While MCP retains relatively high sequence homology with other EEHV types affecting Asian elephants, such as EEHV-5 and EEHV-4, the percent identity for EE2 is substantially lower, reducing the likelihood of meaningful cross-protection against these genotypes